Graves' disease, an autoimmune condition characterized by excessive thyroid hormone secretion and complications including Graves' ophthalmopathy, continues to pose considerable therapeutic challenges. The Graves disease treatment sector is witnessing substantial evolution, with several advanced-stage drug candidates exhibiting remarkable efficacy in controlling both thyroid hyperactivity and...
Spanish 
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt